Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 19 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03011281
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yoon-Kyoung Sung, MD, PhD, MPH Hanyang University Hospital for Rheumatic Diseases